Discover open access scientific publications

Search, annotate, share and cite publications

Publications by J Lundgren

Treatment With a GLP-1 Receptor Agonist Diminishes the Decrease in Free Plasma Leptin During Maintenance of Weight Loss

International Journal of Obesity

English

The Importance of Osmolality for Intermittent Catheterization of the Urethra

English

Related publications

Insights Into GLP-1 Receptor Activation With a Nonpeptide Agonist

Biochemistry

2020

English

Combining SGLT2 Inhibitor and GLP-1 Agonist: Exaggerated Weight Loss in a Morbidly Obese Patient With Type 2 Diabetes

British Journal of Diabetes

2016

English

Protocol for a Randomised Controlled Trial of the Combined Effects of the GLP-1 Receptor Agonist Liraglutide and Exercise on Maintenance of Weight Loss and Health After a Very Low-Calorie Diet

BMJ Open

Medicine

2019

English

Exendin-4, a GLP-1 Receptor Agonist, Stimulates Rat Pituitary-Adrenocortical Axis

English

Patient Preferences for GLP-1 Receptor Agonist Treatment of Type 2 Diabetes Mellitus in Japan: A Discrete Choice Experiment

English

Non-Conventional Glucagon and GLP-1 Receptor Agonist and Antagonist Interplay at the GLP-1 Receptor Revealed in High-Throughput FRET Assays for cAMP

Journal of Biological Chemistry

English

Correction: Nonconventional Glucagon and GLP-1 Receptor Agonist and Antagonist Interplay at the GLP-1 Receptor Revealed in High-Throughput FRET Assays for cAMP.

Journal of Biological Chemistry

English

A Mechanism for Agonist Activation of the Glucagon-Like Peptide-1 (GLP-1) Receptor Through Modelling & Molecular Dynamics

Biochemical and Biophysical Research Communications

English

Patient Preferences for Frequency of Glucagon-Like Peptide-1 Receptor Agonist (GLP-1RA) Injections in the Treatment of Type 2 Diabetes

English

Amanote Research

Discover open access scientific publications

Search, annotate, share and cite publications

Publications by J Lundgren

Treatment With a GLP-1 Receptor Agonist Diminishes the Decrease in Free Plasma Leptin During Maintenance of Weight Loss

The Importance of Osmolality for Intermittent Catheterization of the Urethra

Related publications

Insights Into GLP-1 Receptor Activation With a Nonpeptide Agonist

Combining SGLT2 Inhibitor and GLP-1 Agonist: Exaggerated Weight Loss in a Morbidly Obese Patient With Type 2 Diabetes

Protocol for a Randomised Controlled Trial of the Combined Effects of the GLP-1 Receptor Agonist Liraglutide and Exercise on Maintenance of Weight Loss and Health After a Very Low-Calorie Diet

Exendin-4, a GLP-1 Receptor Agonist, Stimulates Rat Pituitary-Adrenocortical Axis

Patient Preferences for GLP-1 Receptor Agonist Treatment of Type 2 Diabetes Mellitus in Japan: A Discrete Choice Experiment

Non-Conventional Glucagon and GLP-1 Receptor Agonist and Antagonist Interplay at the GLP-1 Receptor Revealed in High-Throughput FRET Assays for cAMP

Correction: Nonconventional Glucagon and GLP-1 Receptor Agonist and Antagonist Interplay at the GLP-1 Receptor Revealed in High-Throughput FRET Assays for cAMP.

A Mechanism for Agonist Activation of the Glucagon-Like Peptide-1 (GLP-1) Receptor Through Modelling & Molecular Dynamics

Patient Preferences for Frequency of Glucagon-Like Peptide-1 Receptor Agonist (GLP-1RA) Injections in the Treatment of Type 2 Diabetes